Author | William D. Tap, MD

Articles

Drug Shows 10-Month Survival Improvement in Sarcoma

June 07, 2015

In this video, Dr. Tap discusses a randomized phase Ib/II trial that found that adding olaratumab to doxorubicin dramatically improved survival in patients with advanced soft-tissue sarcoma.